hearts treated with trifluoperazine , a potent calmodulin inhibitor , exhibited less cellular damage than untreated myocardium as reflected by light microscopy , high-energy phosphate content and the loss of protein and creatine phosphokinase into the perfusate .
C0018787
hearts
C0027061
myocardium